Newsroom
  • March 15 , 2020

    As Coronavirus Deepens Inequality, Inequality Worsens Its Spread

    As the coronavirus spreads across the globe, it appears to be setting off a devastating feedback loop with another of the gravest forces of our time: economic inequality.
    Read more
  • March 2 , 2020

    The rise of the CRO

    Dr Chris Doherty discusses the rise of clinical research organisations (CROs) from his vantage point as managing director at Alderley Park.
    Read more
  • March 1 , 2020

    Chinese biotech bags $50M+ for I/O, autoimmune work, starting with ALK5 inhibitor

    For the last decade or so, many of the more eye-catching Chinese biotech startups share two defining attributes: seasoned execs trained at multinational biopharma companies and a mission to bridge the gap between Western medical breakthroughs and Chinese patients.
    Read more
  • March 1 , 2020

    The top 10 drugs losing U.S. exclusivity in 2020

    Each year, drugmakers face costly losses of exclusivity for big-selling old medicines, forcing them to continually develop and launch new drugs as they strive for growth. While some major brands like Lyrica and Herceptin lost exclusivity last year—with more expected for the coming years—2020 will feature the introduction of important new generics, as well.
    Read more
  • February 25 , 2020

    Biotech company Moderna says its coronavirus vaccine is ready for first tests

    US biotech firm Moderna has shipped an experimental coronavirus vaccine to US government researchers just six weeks after it started working on the immunization.
    Read more
  • February 18 , 2020

    The top 100 biopharma venture investors at the megabillions deal table

    The VC crowd took a step back last year, but nevertheless maintained a furious pace of new investments in therapeutic tech platforms and biotech startups. And the top 100 players completely dominated the megabillions game.
    Read more
  • February 3 , 2020

    Gilead Sciences testing antiviral drug to treat coronavirus

    There is no cure for the deadly Wuhan coronavirus, but several big biotech companies are hoping they can treat the symptoms with existing antiviral medications.
    Read more
  • January 16 , 2020

    Chinese Immuno-Oncology Firm I-Mab's IPO Lands on NASDAQ

    I-Mab is the first Chinese company in two years to try the US boards for an IPO.
    Read more
  • January 10 , 2020

    Biotech Stocks Facing FDA Decision In January 2020

    As we begin the first month of the year 2020, it’s time to take a look at the drug candidates lined up at the FDA altar awaiting the federal agency's decision.
    Read more
  • January 1 , 2020

    First China-made HPV vaccine approved

    BEIJING, Jan. 2 (Xinhua) -- China has approved the first domestically produced vaccine against the cancerogenic human papillomavirus (HPV), according to the National Medical Products Administration (NMPA).
    Read more
  • December 20 , 2019

    Tracon Pharma Acquires US Rights to 3D Medicines/Alphamab PD-L1

    SAN DIEGO, Dec. 20, 2019 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals, Inc.(NASDAQ:TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted therapeutics for cancer, announced today that it has signed a collaborative partnership agreement with 3D Medicines (Beijing) Co., Ltd., a China-based biopharmace
    Read more
  • December 12 , 2019

    GEN:Top 10 Immuno-Oncology Startups of 2019

    Alex Trebek appeared well en route to surviving pancreatic cancer this past summer when his doctors followed up his initial successful chemotherapy with an undisclosed immunotherapy. That move backfired.
    Read more
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Read More
If you would like to get in touch with us, please click here. Contact us